Dana Andersen is the current Chief Technical & Manufacturing Officer at Denali Therapeutics. Dana has over 25 years of experience in the biotech industry. Prior to their current position, they were the Vice President and Global Head of Technical Development Portfolio & Project Management at Genentech from September 1995 to July 2018. Dana also has experience as a post-doc from their time at ETH Zurich from January 1994 to December 1995. Her experience and expertise have been invaluable in their current role at Denali Therapeutics.
Dana Andersen studied chemical engineering at the University of Colorado Boulder for their bachelor's degree. Dana then went on to study chemical engineering at Stanford University for their doctorate degree.
Erica Kratz - VP, Regulatory, Leah Frautschy - VP, Clinical Manufacturing report to Dana Andersen. Some of their coworkers include Wei Dong - VP, Drug Safety, Michael Ostland - VP, Development - Europe, and Cindy Dunkle - Chief People Officer. Dana Andersen reports to Ryan Watts, CEO.
Current role